Skip to main content
Top
Published in: Pediatric Drugs 5/2015

01-10-2015 | Therapy in Practice

Pharmacological Management of Pediatric Patients with Comorbid Attention-Deficit Hyperactivity Disorder Oppositional Defiant Disorder

Author: Daniel F. Connor

Published in: Pediatric Drugs | Issue 5/2015

Login to get access

Abstract

Attention-deficit hyperactivity disorder (ADHD) is a common developmental neurobiological condition of childhood characterized by age-inappropriate degrees of hyperactivity/impulsivity and inattention to tasks requiring sustained vigilance. Oppositional defiant disorder (ODD) is an externalizing behavior disorder characterized by difficulties with emotional and behavioral regulation that frequently brings the child into conflict with authority figures. In the clinical setting, ODD is the most common ADHD comorbidity. The combination portends more severe symptom severity, daily impairment, and a more at-risk prognosis than either disorder alone. We briefly review the literature on the characteristics and treatment of the ADHD and ODD child. A clinical approach to evaluation and treatment of ADHD and ODD is then presented. This approach emphasizes the importance of child and parent psychoeducation about the two disorders alone and in combination, the importance of behavioral management therapy approaches, the possible need for school and academic supports, and the decision to use evidence-based stimulant or non-stimulant ADHD medications depending on symptom severity combined with child and parental wishes and choice.
Literature
1.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Publishing; 2013. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Publishing; 2013.
2.
go back to reference World Health Organization. International classification of diseases and related health problems. Geneva, Switzerland: WHO; 1992. World Health Organization. International classification of diseases and related health problems. Geneva, Switzerland: WHO; 1992.
3.
go back to reference Multimodal Treatment of ADHD Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073–86.CrossRef Multimodal Treatment of ADHD Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073–86.CrossRef
4.
go back to reference Pliszka SR. Comorbid psychiatric disorder in children with ADHD. In: Barkley RA, editor. Attention-deficit hyperactivity disorder: a handbook for diagnosis & treatment. 4th ed. New York: Guilford Press; 2015. p. 140–68. Pliszka SR. Comorbid psychiatric disorder in children with ADHD. In: Barkley RA, editor. Attention-deficit hyperactivity disorder: a handbook for diagnosis & treatment. 4th ed. New York: Guilford Press; 2015. p. 140–68.
5.
go back to reference Swanson J, Arnold LE, Kraemer H, et al. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. J Atten Disord. 2008;12(1):4–14.CrossRefPubMed Swanson J, Arnold LE, Kraemer H, et al. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. J Atten Disord. 2008;12(1):4–14.CrossRefPubMed
6.
go back to reference Barkley RA, Murphy KR, Fischer M. ADHD in adults. What the science says. New York: Guilford Press; 2008. Barkley RA, Murphy KR, Fischer M. ADHD in adults. What the science says. New York: Guilford Press; 2008.
7.
go back to reference Connor DF, Doerfler LA. ADHD with comorbid oppositional defiant disorder or conduct disorder: discrete or nondistinct disruptive behavior disorders? J Atten Disord. 2008;12(2):126–34.CrossRefPubMed Connor DF, Doerfler LA. ADHD with comorbid oppositional defiant disorder or conduct disorder: discrete or nondistinct disruptive behavior disorders? J Atten Disord. 2008;12(2):126–34.CrossRefPubMed
8.
go back to reference Connor DF, Steeber J, McBurnett K. A review of attention-deficit/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder. J Dev Behav Pediatr. 2010;31(5):427–40.CrossRefPubMed Connor DF, Steeber J, McBurnett K. A review of attention-deficit/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder. J Dev Behav Pediatr. 2010;31(5):427–40.CrossRefPubMed
9.
go back to reference Barkley RA, Fischer M, Smallish L, et al. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry. 2006;45(2):192–202.CrossRefPubMed Barkley RA, Fischer M, Smallish L, et al. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry. 2006;45(2):192–202.CrossRefPubMed
10.
go back to reference Beauchaine TP, Hinshaw SP, Pang KL. Comrobidity of attention-deficit/hyperactivity disorder and early-onset conduct disorder: Biological, environmental, and developmental mechanisms. Clin Psychol: Sci Pract. 2010;17:327–36. Beauchaine TP, Hinshaw SP, Pang KL. Comrobidity of attention-deficit/hyperactivity disorder and early-onset conduct disorder: Biological, environmental, and developmental mechanisms. Clin Psychol: Sci Pract. 2010;17:327–36.
11.
go back to reference Waldman ID, Lahey BB. Oppositional defiant disorder, conduct disorder, and juvenile delinquency. In: Beauchaine TP, Hinshaw SP, editors. Child and adolescent psychopathology. 2nd ed. Hoboken, New Jersey: Wiley; 2013. p. 411–52. Waldman ID, Lahey BB. Oppositional defiant disorder, conduct disorder, and juvenile delinquency. In: Beauchaine TP, Hinshaw SP, editors. Child and adolescent psychopathology. 2nd ed. Hoboken, New Jersey: Wiley; 2013. p. 411–52.
12.
go back to reference Taylor E, Chadwick O, Heptinstall E, et al. Hyperactivity and conduct problems as risk factors for adolescent development. J Am Acad Child Adolesc Psychiatry. 1996;35(9):1213–26.CrossRefPubMed Taylor E, Chadwick O, Heptinstall E, et al. Hyperactivity and conduct problems as risk factors for adolescent development. J Am Acad Child Adolesc Psychiatry. 1996;35(9):1213–26.CrossRefPubMed
13.
go back to reference De Pauw SS, Mervielde I. Temperament, personality and developmental psychopathology: a review based on the conceptual dimensions underlying childhood traits. Child Psychiatry Hum Dev. 2010;41(3):313–29.CrossRefPubMed De Pauw SS, Mervielde I. Temperament, personality and developmental psychopathology: a review based on the conceptual dimensions underlying childhood traits. Child Psychiatry Hum Dev. 2010;41(3):313–29.CrossRefPubMed
14.
go back to reference Dishion TJ, Racer KH. Development of adult antisocial behavior. In: Beauchaine TP, Hinshaw SP, editors. Child and adolescent psychopathology. 2nd ed. Hoboken, New Jersey: Wiley; 2013. p. 453–87. Dishion TJ, Racer KH. Development of adult antisocial behavior. In: Beauchaine TP, Hinshaw SP, editors. Child and adolescent psychopathology. 2nd ed. Hoboken, New Jersey: Wiley; 2013. p. 453–87.
15.
go back to reference Steiner H, Remsing L. Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(1):126–41.CrossRefPubMed Steiner H, Remsing L. Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(1):126–41.CrossRefPubMed
16.
go back to reference Lahey BB, Waldman ID, McBurnett K. Annotation: the development of antisocial behavior: an integrative causal model. J Child Psychol Psychiatry. 1999;40(5):669–82.CrossRefPubMed Lahey BB, Waldman ID, McBurnett K. Annotation: the development of antisocial behavior: an integrative causal model. J Child Psychol Psychiatry. 1999;40(5):669–82.CrossRefPubMed
17.
go back to reference Pfiffner LJ, McBurnett K, Rathouz PJ, et al. Family correlates of oppositional and conduct disorders in children with attention deficit/hyperactivity disorder. J Abnorm Child Psychol. 2005;33(5):551–63.CrossRefPubMed Pfiffner LJ, McBurnett K, Rathouz PJ, et al. Family correlates of oppositional and conduct disorders in children with attention deficit/hyperactivity disorder. J Abnorm Child Psychol. 2005;33(5):551–63.CrossRefPubMed
18.
go back to reference Jensen PS, Hinshaw SP, Swanson JM, et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr. 2001;22(1):60–73.CrossRefPubMed Jensen PS, Hinshaw SP, Swanson JM, et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr. 2001;22(1):60–73.CrossRefPubMed
19.
go back to reference Burke JD, Loeber R, Lahey BB, et al. Developmental transitions among affective and behavioral disorders in adolescent boys. J Child Psychol Psychiatry. 2005;46(11):1200–10.CrossRefPubMed Burke JD, Loeber R, Lahey BB, et al. Developmental transitions among affective and behavioral disorders in adolescent boys. J Child Psychol Psychiatry. 2005;46(11):1200–10.CrossRefPubMed
20.
go back to reference Loeber R, Green SM, Lahey BB, et al. Findings on disruptive behavior disorders from the first decade of the Developmental Trends Study. Clin Child Fam Psychol Rev. 2000;3(1):37–60.CrossRefPubMed Loeber R, Green SM, Lahey BB, et al. Findings on disruptive behavior disorders from the first decade of the Developmental Trends Study. Clin Child Fam Psychol Rev. 2000;3(1):37–60.CrossRefPubMed
21.
go back to reference Villodas MT, Pfiffner LJ, McBurnett K. Prevention of serious conduct problems in youth with attention deficit/hyperactivity disorder. Expert Rev Neurother. 2012;12(10):1253–63.PubMedCentralCrossRefPubMed Villodas MT, Pfiffner LJ, McBurnett K. Prevention of serious conduct problems in youth with attention deficit/hyperactivity disorder. Expert Rev Neurother. 2012;12(10):1253–63.PubMedCentralCrossRefPubMed
22.
go back to reference Satterfield JH, Faller KJ, Crinella FM, et al. A 30-year prospective follow-up study of hyperactive boys with conduct problems: adult criminality. J Am Acad Child Adolesc Psychiatry. 2007;46(5):601–10.CrossRefPubMed Satterfield JH, Faller KJ, Crinella FM, et al. A 30-year prospective follow-up study of hyperactive boys with conduct problems: adult criminality. J Am Acad Child Adolesc Psychiatry. 2007;46(5):601–10.CrossRefPubMed
23.
go back to reference American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1997;36:85S–121S.CrossRef American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1997;36:85S–121S.CrossRef
24.
go back to reference American Academy of Child and Adolescent Psychiatry. Practice parameters for the psychiatric assessment of children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997;31(10 Suppl):1386–402. American Academy of Child and Adolescent Psychiatry. Practice parameters for the psychiatric assessment of children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997;31(10 Suppl):1386–402.
25.
go back to reference Achenbach TM, Ruffle TM. The Child Behavior Checklist and related forms for assessing behavioral/emotional problems and competencies. Pediatr Rev. 2000;21(8):265–71.CrossRefPubMed Achenbach TM, Ruffle TM. The Child Behavior Checklist and related forms for assessing behavioral/emotional problems and competencies. Pediatr Rev. 2000;21(8):265–71.CrossRefPubMed
26.
go back to reference Conners CK. Conners Rating Scales-Revised, 3rd edn. North Tonawanda, NY: Multi-Health Systems; 2008. Conners CK. Conners Rating Scales-Revised, 3rd edn. North Tonawanda, NY: Multi-Health Systems; 2008.
27.
go back to reference Reynolds C, Kamphaus R. Behavioral assessment system for children. Circle Pines, MN: American Guidance Service; 2004. Reynolds C, Kamphaus R. Behavioral assessment system for children. Circle Pines, MN: American Guidance Service; 2004.
30.
go back to reference Barkley RA. Attention-deficit hyperactivity disorder. A handbook for diagnosis & treatment. 4th ed. New York: Guilford Press; 2015. Barkley RA. Attention-deficit hyperactivity disorder. A handbook for diagnosis & treatment. 4th ed. New York: Guilford Press; 2015.
31.
go back to reference Sonuga-Barke EJ. Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry. 2005;57(11):1231–8.CrossRefPubMed Sonuga-Barke EJ. Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry. 2005;57(11):1231–8.CrossRefPubMed
32.
go back to reference Nigg JT, Willcutt EG, Doyle AE, et al. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biol Psychiatry. 2005;57(11):1224–30.CrossRefPubMed Nigg JT, Willcutt EG, Doyle AE, et al. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biol Psychiatry. 2005;57(11):1224–30.CrossRefPubMed
33.
go back to reference Pfiffner LJ, Haack LM. Behavior management for school-aged children with ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):731–46.CrossRefPubMed Pfiffner LJ, Haack LM. Behavior management for school-aged children with ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):731–46.CrossRefPubMed
34.
go back to reference Evans SW, Schultz BK, Sadler JM. Safety and efficacy of psychosocial interventions used to treat children with attention-deficit/hyperactivity disorder. Pediatr Ann. 2008;37(1):52–9.CrossRefPubMed Evans SW, Schultz BK, Sadler JM. Safety and efficacy of psychosocial interventions used to treat children with attention-deficit/hyperactivity disorder. Pediatr Ann. 2008;37(1):52–9.CrossRefPubMed
35.
go back to reference Comer JS, Chow C, Chan PT, et al. Psychosocial treatment efficacy for disruptive behavior problems in very young children: a meta-analytic examination. J Am Acad Child Adolesc Psychiatry. 2013;52(1):26–36.PubMedCentralCrossRefPubMed Comer JS, Chow C, Chan PT, et al. Psychosocial treatment efficacy for disruptive behavior problems in very young children: a meta-analytic examination. J Am Acad Child Adolesc Psychiatry. 2013;52(1):26–36.PubMedCentralCrossRefPubMed
36.
go back to reference Faraone SV, Antshel KM. Towards an evidence-based taxonomy of nonpharmacologic treatments for ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):965–72.CrossRefPubMed Faraone SV, Antshel KM. Towards an evidence-based taxonomy of nonpharmacologic treatments for ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):965–72.CrossRefPubMed
37.
go back to reference Spencer TJ, Abikoff HB, Connor DF, et al. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study. Clin Ther. 2006;28(3):402–18.CrossRefPubMed Spencer TJ, Abikoff HB, Connor DF, et al. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study. Clin Ther. 2006;28(3):402–18.CrossRefPubMed
38.
go back to reference Connor DF, Findling RL, Kollins SH, et al. Effects of guanfacine extended release on oppositional symptoms in children aged 6–12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial. CNS Drugs. 2010;24(9):755–68.PubMed Connor DF, Findling RL, Kollins SH, et al. Effects of guanfacine extended release on oppositional symptoms in children aged 6–12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial. CNS Drugs. 2010;24(9):755–68.PubMed
39.
go back to reference Thiruchelvam D, Charach A, Schachar RJ. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2001;40(8):922–8.CrossRefPubMed Thiruchelvam D, Charach A, Schachar RJ. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2001;40(8):922–8.CrossRefPubMed
40.
go back to reference Multimodal Treatment of ADHD Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1088–96.CrossRef Multimodal Treatment of ADHD Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1088–96.CrossRef
41.
go back to reference Multimodal Treatment of ADHD Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics. 2004;113(4):754–61.CrossRef Multimodal Treatment of ADHD Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics. 2004;113(4):754–61.CrossRef
42.
go back to reference Faraone SV, Buitelaar J. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry. 2010;19(4):353–64.CrossRefPubMed Faraone SV, Buitelaar J. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry. 2010;19(4):353–64.CrossRefPubMed
43.
go back to reference Cheng JYW, Chen RYL, Ko JSN, et al. Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-review. Psychopharmacology. 2007;194:197–209.CrossRefPubMed Cheng JYW, Chen RYL, Ko JSN, et al. Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-review. Psychopharmacology. 2007;194:197–209.CrossRefPubMed
44.
go back to reference Michelson D, Faries D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled. Dose Response Study. Pediatrics. 2001;108(5):1–9.CrossRef Michelson D, Faries D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled. Dose Response Study. Pediatrics. 2001;108(5):1–9.CrossRef
45.
go back to reference Biederman J, Melmed RD, Patel A, et al. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics. 2008;121(1):e73–84.CrossRefPubMed Biederman J, Melmed RD, Patel A, et al. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics. 2008;121(1):e73–84.CrossRefPubMed
46.
go back to reference Sallee F, Connor DF, Newcorn JH. A review of the rationale and clinical utilization of alpha2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders. J Child Adolesc Psychopharmacol. 2013;23(5):308–19.CrossRefPubMed Sallee F, Connor DF, Newcorn JH. A review of the rationale and clinical utilization of alpha2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders. J Child Adolesc Psychopharmacol. 2013;23(5):308–19.CrossRefPubMed
47.
go back to reference Sallee FR, McGough J, Wigal T, et al. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2009;48(2):155–65.CrossRefPubMed Sallee FR, McGough J, Wigal T, et al. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2009;48(2):155–65.CrossRefPubMed
48.
go back to reference Blader JC, Pliszka SR, Jensen PS, et al. Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD. Pediatrics. 2010;126(4):e796–806.PubMedCentralCrossRefPubMed Blader JC, Pliszka SR, Jensen PS, et al. Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD. Pediatrics. 2010;126(4):e796–806.PubMedCentralCrossRefPubMed
49.
go back to reference Schachar RJ, Tannock R, Cunningham CE, et al. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J Am Acad Child Adolesc Psychiatry. 1997;36(6):754–63.CrossRefPubMed Schachar RJ, Tannock R, Cunningham CE, et al. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J Am Acad Child Adolesc Psychiatry. 1997;36(6):754–63.CrossRefPubMed
50.
go back to reference Bangs ME, Hazell P, Danckaerts M, et al. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Pediatrics. 2008;121(2):e314–20.CrossRefPubMed Bangs ME, Hazell P, Danckaerts M, et al. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Pediatrics. 2008;121(2):e314–20.CrossRefPubMed
51.
go back to reference Newcorn JH, Spencer TJ, Biederman J, et al. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(3):240–8.CrossRefPubMed Newcorn JH, Spencer TJ, Biederman J, et al. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(3):240–8.CrossRefPubMed
52.
go back to reference Palumbo DR, Sallee FR, Pelham WE Jr, et al. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. J Am Acad Child Adolesc Psychiatry. 2008;47(2):180–8.CrossRefPubMed Palumbo DR, Sallee FR, Pelham WE Jr, et al. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. J Am Acad Child Adolesc Psychiatry. 2008;47(2):180–8.CrossRefPubMed
53.
go back to reference Findling RL, McBurnett K, White C, et al. Guanfacine extended release adjunctive to a psychostimulant in the treatment of comorbid oppositional symptoms in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2014;24(5):245–52.PubMedCentralCrossRefPubMed Findling RL, McBurnett K, White C, et al. Guanfacine extended release adjunctive to a psychostimulant in the treatment of comorbid oppositional symptoms in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2014;24(5):245–52.PubMedCentralCrossRefPubMed
54.
go back to reference Gadow KD, Nolan EE, Sverd J, et al. Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD. J Child Neurol. 2008;23(9):981–90.CrossRefPubMed Gadow KD, Nolan EE, Sverd J, et al. Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD. J Child Neurol. 2008;23(9):981–90.CrossRefPubMed
55.
go back to reference Aman MG, Bukstein OG, Gadow KD, et al. What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder? J Am Acad Child Adolesc Psychiatry. 2014;53(1):47 e1–60 e1.CrossRef Aman MG, Bukstein OG, Gadow KD, et al. What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder? J Am Acad Child Adolesc Psychiatry. 2014;53(1):47 e1–60 e1.CrossRef
56.
go back to reference DuPaul GJ, Gormley MJ, Laracy SD. School-based interventions for elementary school students with ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):687–97.CrossRefPubMed DuPaul GJ, Gormley MJ, Laracy SD. School-based interventions for elementary school students with ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):687–97.CrossRefPubMed
57.
go back to reference Robin AL. Family therapy for adolescents with ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):747–56.CrossRefPubMed Robin AL. Family therapy for adolescents with ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):747–56.CrossRefPubMed
58.
go back to reference Mikami AY, Jia M, Na JJ. Social skills training. Child Adolesc Psychiatr Clin N Am. 2014;23(4):775–88.CrossRefPubMed Mikami AY, Jia M, Na JJ. Social skills training. Child Adolesc Psychiatr Clin N Am. 2014;23(4):775–88.CrossRefPubMed
59.
go back to reference Antshel KM, Olszewski AK. Cognitive behavioral therapy for adolescents with ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):825–42.CrossRefPubMed Antshel KM, Olszewski AK. Cognitive behavioral therapy for adolescents with ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):825–42.CrossRefPubMed
60.
go back to reference Antshel KM. Psychosocial interventions in attention-deficit/hyperactivity disorder: update. Child Adolesc Psychiatr Clin N Am. 2015;24(1):79–97.CrossRefPubMed Antshel KM. Psychosocial interventions in attention-deficit/hyperactivity disorder: update. Child Adolesc Psychiatr Clin N Am. 2015;24(1):79–97.CrossRefPubMed
61.
go back to reference Connor DF. Stimulant and nonstimulant medications for childhood ADHD. In: Barkley RA, editor. Attention-Deficit hyperactivity disorder: a handbook for diagnosis & treatment. 4th ed. New York: Guilford Press; 2015. p. 666–85. Connor DF. Stimulant and nonstimulant medications for childhood ADHD. In: Barkley RA, editor. Attention-Deficit hyperactivity disorder: a handbook for diagnosis & treatment. 4th ed. New York: Guilford Press; 2015. p. 666–85.
62.
go back to reference American Academy of Pediatrics. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108(4):1033–44.CrossRef American Academy of Pediatrics. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108(4):1033–44.CrossRef
63.
go back to reference Connor DF, Glatt SJ, Lopez ID, et al. Psychopharmacology and aggression. I: a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry. 2002;41(3):253–61.CrossRefPubMed Connor DF, Glatt SJ, Lopez ID, et al. Psychopharmacology and aggression. I: a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry. 2002;41(3):253–61.CrossRefPubMed
64.
go back to reference Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921.CrossRefPubMed Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921.CrossRefPubMed
65.
go back to reference Greenhill L, Beyer DH, Finkleson J, et al. Guidelines and algorithms for the use of methylphenidate in children with attention-deficit/ hyperactivity disorder. J Atten Disord. 2002;6(Suppl 1):S89–100.PubMed Greenhill L, Beyer DH, Finkleson J, et al. Guidelines and algorithms for the use of methylphenidate in children with attention-deficit/ hyperactivity disorder. J Atten Disord. 2002;6(Suppl 1):S89–100.PubMed
66.
go back to reference Jain R, Segal S, Kollins SH, et al. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011;50(2):171–9.CrossRefPubMed Jain R, Segal S, Kollins SH, et al. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011;50(2):171–9.CrossRefPubMed
67.
go back to reference Gadow KD, Arnold LE, Molina BS, et al. Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression. J Am Acad Child Adolesc Psychiatry. 2014;53(9):948 e1–959 e1.CrossRefPubMed Gadow KD, Arnold LE, Molina BS, et al. Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression. J Am Acad Child Adolesc Psychiatry. 2014;53(9):948 e1–959 e1.CrossRefPubMed
68.
go back to reference Maayan L, Correll CU. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol. 2011;21(6):517–35.CrossRefPubMed Maayan L, Correll CU. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol. 2011;21(6):517–35.CrossRefPubMed
Metadata
Title
Pharmacological Management of Pediatric Patients with Comorbid Attention-Deficit Hyperactivity Disorder Oppositional Defiant Disorder
Author
Daniel F. Connor
Publication date
01-10-2015
Publisher
Springer International Publishing
Published in
Pediatric Drugs / Issue 5/2015
Print ISSN: 1174-5878
Electronic ISSN: 1179-2019
DOI
https://doi.org/10.1007/s40272-015-0143-3

Other articles of this Issue 5/2015

Pediatric Drugs 5/2015 Go to the issue